These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 8041301

  • 61. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S, Yang Y, Sadegh-Nasseri S, Ashwell JD.
    J Immunol; 1993 Mar 15; 150(6):2211-21. PubMed ID: 8450208
    [Abstract] [Full Text] [Related]

  • 62. Differential response of CD4+ V7+ and CD4+ V7- T cells to T cell receptor-dependent signals: CD4+ V7+ T cells are co-stimulation independent and anti-V7 antibody blocks the induction of anergy by bacterial superantigen.
    Soares LR, Rivas A, Ruegg C, Engleman EG.
    Eur J Immunol; 1997 Jun 15; 27(6):1413-21. PubMed ID: 9209493
    [Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67. Human eosinophils as antigen-presenting cells: relative efficiency for superantigen- and antigen-induced CD4+ T-cell proliferation.
    Mawhorter SD, Kazura JW, Boom WH.
    Immunology; 1994 Apr 15; 81(4):584-91. PubMed ID: 7518797
    [Abstract] [Full Text] [Related]

  • 68. Two novel superantigens found in both group A and group C Streptococcus.
    Proft T, Webb PD, Handley V, Fraser JD.
    Infect Immun; 2003 Mar 15; 71(3):1361-9. PubMed ID: 12595453
    [Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71. Similar superantigen gene profiles and superantigen activity in norwegian isolates of invasive and non-invasive group a streptococci.
    Michaelsen TE, Andreasson IK, Langerud BK, Caugant DA.
    Scand J Immunol; 2011 Nov 15; 74(5):423-9. PubMed ID: 21707691
    [Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73. Fine antigen specificity of human gamma delta T cell lines (V gamma 9+) established by repetitive stimulation with a serotype (KTH-1) of a gram-positive bacterium, Streptococcus sanguis.
    Mochizuki M, Suzuki N, Takeno M, Nagafuchi H, Harada T, Kaneoka H, Yamashita N, Hirayama K, Nakajima T, Mizushima Y.
    Eur J Immunol; 1994 Jul 15; 24(7):1536-43. PubMed ID: 7517873
    [Abstract] [Full Text] [Related]

  • 74. Antigen targeting to major histocompatibility complex class II with streptococcal mitogenic exotoxin Z-2 M1, a superantigen-based vaccine carrier.
    Radcliff FJ, Loh JM, Ha B, Schuhbauer D, McCluskey J, Fraser JD.
    Clin Vaccine Immunol; 2012 Apr 15; 19(4):574-86. PubMed ID: 22301693
    [Abstract] [Full Text] [Related]

  • 75. Group A streptococcal M protein binds to several human cell types but not via MHC class II molecules.
    Wagner B, Schmidt KH, Fleischer B, Reichardt W, Wagner M.
    Adv Exp Med Biol; 1997 Apr 15; 418():559-61. PubMed ID: 9331713
    [No Abstract] [Full Text] [Related]

  • 76. The superantigenic activity of streptococcal pyrogenic exotoxin B is independent of the protease activity.
    Eriksson A, Norgren M.
    FEMS Immunol Med Microbiol; 1999 Sep 15; 25(4):355-63. PubMed ID: 10497866
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
    de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE.
    J Exp Med; 1991 Oct 01; 174(4):915-24. PubMed ID: 1655948
    [Abstract] [Full Text] [Related]

  • 79. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
    Maurer DH, Hanke JH, Mickelson E, Rich RR, Pollack MS.
    J Immunol; 1987 Aug 01; 139(3):715-23. PubMed ID: 3110281
    [Abstract] [Full Text] [Related]

  • 80. The required interaction between monocytes and peripheral blood T lymphocytes (T-PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T-PBL subsets.
    Huet S, Boumsell L, Dausset J, Degos L, Bernard A.
    Eur J Immunol; 1988 Aug 01; 18(8):1187-94. PubMed ID: 2901355
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.